Dalmane and Slow rhr - a phase IV clinical study of FDA data

Summary:

Slow rhr is reported as a side effect among people who take Dalmane (flurazepam hydrochloride), especially for people who are female, 60+ old, also take Neurontin, and have Breast cancer.

The phase IV clinical study analyzes which people have Slow rhr when taking Dalmane. It is created by eHealthMe based on reports of 1,224 people who have side effects when taking Dalmane from the FDA, and is updated regularly.

What is Dalmane?

Dalmane has active ingredients of flurazepam hydrochloride. It is often used in insomnia. eHealthMe is studying from 1,269 Dalmane users. Check the latest studies of Dalmane.

What is Slow rhr?

Slow rhr is found to be associated with 2,917 drugs and 3,008 conditions by eHealthMe. Check the latest studies of Slow rhr.



On May, 01, 2026

1,224 people reported to have side effects when taking Dalmane.
Among them, 24 people (1.96%) have Slow rhr.

Could Dalmane cause Slow rhr?

Among these 24 people:

What is the gender of people who have Slow rhr when taking Dalmane? *

  • female: 54.17 %
  • male: 45.83 %

What is the age of people who have Slow rhr when taking Dalmane? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 18.18 %
  • 40-49: 0.0 %
  • 50-59: 13.64 %
  • 60+: 68.18 %

What are other drugs people take besides Dalmane? *

  1. Neurontin: 15 people, 62.50%
  2. Lasix: 14 people, 58.33%
  3. Vioxx: 14 people, 58.33%
  4. Motrin: 14 people, 58.33%
  5. Percocet: 13 people, 54.17%
  6. Colace: 13 people, 54.17%
  7. Bactrim: 12 people, 50.00%
  8. Betoptic: 11 people, 45.83%
  9. Famvir: 11 people, 45.83%
  10. Femara: 11 people, 45.83%

What are other side effects people have besides Slow rhr? *

  1. Stress And Anxiety: 19 people, 79.17%
  2. Dyspnea (difficult or laboured breathing): 17 people, 70.83%
  3. Confusional State: 16 people, 66.67%
  4. Memory Loss: 16 people, 66.67%
  5. Pain: 15 people, 62.50%
  6. Hypotonia (low muscle tone): 15 people, 62.50%
  7. Rashes (redness): 14 people, 58.33%
  8. Weight Loss: 14 people, 58.33%
  9. Cardiac Failure Congestive: 14 people, 58.33%
  10. Oedema Peripheral (superficial swelling): 13 people, 54.17%

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 10 people, 41.67%
  2. Breast Cancer: 10 people, 41.67%
  3. Pain: 7 people, 29.17%
  4. Pain In Extremity: 2 people, 8.33%
  5. Muscle Spasms (muscle contraction): 2 people, 8.33%
  6. Laxative Supportive Care: 2 people, 8.33%
  7. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 8.33%
  8. Drowsiness: 2 people, 8.33%
  9. Constipation: 2 people, 8.33%
  10. Procedural Vomiting: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Dalmane and have Slow rhr?

- Check whether Slow rhr is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dalmane:

Slow rhr treatments and more:

How severe was Slow rhr and when was it recovered:

Expand to all the drugs that have ingredients of flurazepam hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dalmane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Slow rhr:

Browse all the conditions that are associated with Slow rhr:


How the study uses the data?

The study uses data from the FDA. It is based on flurazepam hydrochloride (the active ingredients of Dalmane) and Dalmane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: